ID26955A - HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDIN - Google Patents
HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDINInfo
- Publication number
- ID26955A ID26955A IDW20002479A ID20002479A ID26955A ID 26955 A ID26955 A ID 26955A ID W20002479 A IDW20002479 A ID W20002479A ID 20002479 A ID20002479 A ID 20002479A ID 26955 A ID26955 A ID 26955A
- Authority
- ID
- Indonesia
- Prior art keywords
- lamivudin
- zidovudin
- homogen
- abacavir
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26955A true ID26955A (en) | 2001-02-22 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002479A ID26955A (en) | 1998-04-29 | 1999-04-26 | HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDIN |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| WO2003090762A1 (en) * | 2002-04-23 | 2003-11-06 | Lupin Limited | Long acting compositions comprising zidovudine and lamivudine |
| AR040242A1 (en) * | 2002-06-04 | 2005-03-23 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITIONS |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| US20110104267A1 (en) * | 2005-04-25 | 2011-05-05 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| WO2007013047A2 (en) * | 2005-07-29 | 2007-02-01 | Ranbaxy Laboratories Limited | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| RU2010117269A (en) * | 2007-10-02 | 2011-11-10 | Эмори Юнивёсити (Us) | ACTIVE COMBINATIONS OF ZIDOVUDIN AND MEDICINES WHICH ARE SELECTIVE FOR THE K65R MUTATION IN HIV POLYMERASE |
| US20110117193A1 (en) * | 2008-01-17 | 2011-05-19 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| MX367937B (en) | 2010-01-27 | 2019-09-12 | Viiv Healthcare Co | Antiviral therapy. |
| WO2011156594A2 (en) | 2010-06-09 | 2011-12-15 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
| EP2822560A1 (en) | 2012-03-05 | 2015-01-14 | Cipla Limited | Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine |
| JP2015534973A (en) | 2012-10-23 | 2015-12-07 | シプラ・リミテッド | Antiretroviral pharmaceutical composition |
| PT3007695T (en) | 2013-06-13 | 2024-03-07 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Application Discontinuation
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Application Discontinuation
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
- 2000-10-27 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AP2000001971A0 (en) | 2000-12-31 |
| HRP20000732A2 (en) | 2001-02-28 |
| CA2330391A1 (en) | 1999-11-04 |
| EE200000646A (en) | 2002-04-15 |
| HUP0101622A3 (en) | 2003-09-29 |
| EP1083932A1 (en) | 2001-03-21 |
| NZ507745A (en) | 2004-07-30 |
| JP2002512979A (en) | 2002-05-08 |
| TR200003157T2 (en) | 2001-01-22 |
| CN1411380A (en) | 2003-04-16 |
| HUP0101622A2 (en) | 2002-03-28 |
| GB9809213D0 (en) | 1998-07-01 |
| PL343710A1 (en) | 2001-08-27 |
| NO20005418D0 (en) | 2000-10-27 |
| IS5675A (en) | 2000-10-20 |
| EA200000997A1 (en) | 2001-06-25 |
| BR9910071A (en) | 2000-12-26 |
| SK16212000A3 (en) | 2001-07-10 |
| IL139181A0 (en) | 2001-11-25 |
| NO20005418L (en) | 2000-11-29 |
| AU4135599A (en) | 1999-11-16 |
| ZA200005922B (en) | 2001-10-23 |
| KR20010043128A (en) | 2001-05-25 |
| WO1999055372A1 (en) | 1999-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID23673A (en) | PHARMACEUTICAL FORMULATION CONSIST OF AMOXICILIN AND KLAVULANAT | |
| ID26955A (en) | HOMOGEN PHARMACEUTICAL COMPOSITION CONSIST OF ABACAVIR, LAMIVUDIN AND ZIDOVUDIN | |
| ID29994A (en) | PHARMACEUTICAL COMPOSITION FOR AGAINST CCR5 CONSIST OF ANILIDA DECREASES | |
| ID27922A (en) | PHARMACICAL COMPOSITION AND USE OF ANDROST-5-ENA-3β, 17β-DIOL | |
| IS5665A (en) | Pharmaceutical pressure spray composition | |
| PT1066027E (en) | PHARMACEUTICAL COMPOSITION OF TOPIRAMATO | |
| EE200300145A (en) | Aza and polyazanaphthalenylcarboxamides and pharmaceutical composition | |
| ID29437A (en) | COMBINATIONS OF FORMOTEROL AND FLUTIKASON PROPIONATE FOR ASMA | |
| ID21683A (en) | SOLID PHARMACEUTICAL COMPOSITION CONSIST OF CYCLOSPORINE AND ANIONIC SURFACE MATERIALS | |
| ID28270A (en) | COMPOSITION AND FORMULATION OF PEPTIDES AND USES | |
| PL354168A1 (en) | Pharmaceutical composition of nateglinide and another antidiabetcagent | |
| PT998272E (en) | PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT | |
| ID18663A (en) | COMPOSITION OF PHARMACEUTICAL PLATED PHARMACEUTICALS | |
| EE200000468A (en) | The compounds, their use and the pharmaceutical composition | |
| ID28709A (en) | COMBINATIONS OF TWO OR MORE ACTIVE MATERIALS USING MICROCAPSULATION FORMULATIONS | |
| EE03904B1 (en) | Granule, pharmaceutical dosage form, method of preparation of the granules and drug-coated granules | |
| ID29026A (en) | PHARMACEUTICAL COMPOSITION CONSIST OF ENTACAPONE OR NITECAPONE AND CROSS-CONNECTED CELLULOSE | |
| HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
| HK1015351A1 (en) | Substituted amino compounds and their use as analgesic active substances | |
| ID26137A (en) | NEW PHARMACEUTICAL COMPOSITION OF TRIFOSPHATE URIDIN | |
| ID25535A (en) | THE COMPOSITION OF THE BODY CONTAINS FROM THE SOFTWARE DRUGS THAT ARE TRAPPED OUT OF ITS DISTANCE | |
| ID20137A (en) | PROPANOLAMINA DECREASED, THE PROCESS OF MAKING, PHARMACEUTICAL PROPERTIES THAT CONTAIN THIS COMPOUND, AND ITS USE | |
| EE04681B1 (en) | 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition | |
| ID26040A (en) | CATALYTIC COMPOSITION CONSIST OF TITANIUM COMPOUND, AMINA PHOSFOR COMPOUND; MANUFACTURE AND USE OF IT | |
| PL361518A1 (en) | Application of substance and pharmaceutical composition |